COSCIENS Biopharma Inc. (CSCID) Cash flow
Market cap
$36.82M
P/E ratio
| 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | - | - | 0 | 0 | 0 | 0 | 0 | 2 | 1 |
| Stock-based compensation | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | -0 |
| Cash from operations | -23 | 7 | -11 | -4 | -9 | -14 | -17 | -15 | -8 |
| Capital expenditures | -0 | -0 | - | - | -0 | -0 | -0 | -1 | -1 |
| Cash from investing | 0 | -0 | 0 | 0 | -1 | -0 | 1 | 25 | -0 |
| Cash from financing | 8 | - | 4 | 20 | 51 | -0 | -0 | -1 | -0 |
| Free cash flow | - | - | |||||||
| FCF margin (%) | - | - |